Get the word out. Share this event with your colleagues. Click to post.

Emerging Issues in Life Science Cross-Border Initiatives

Emerging Issues in Life Science Cross-Border Initiatives
June 28, 2023 | 5:30 pm – 7:00pm  | Q & A and Networking 7:00pm – 8:00pm
Online registration is now closed. Please call Customer relations at 212 382 6663 to register or for assistance.

Format: In-Person

Program Fee:
Free for Members and Non-Lawyers | $15 Non-Members
Non-Lawyers please call Customer Relations at 212-382-6663 to register. 


Join us for a discussion on the emerging issues in life science cross-border transactions, especially focusing on the pharmaceutical licensing transactions (license-in/out) in China, key considerations for Chinese biotech companies to go public, and hot Chinese regulatory issues on clinical trials, registrational pathway, and human genetic resources (HGR).  

Aaron GU, Han Kun Law Offices

Ian Woo, President and Chief Financial Officer, Everest Medicines
Enna Weng, Managing Director,  Freedom Capital Markets
Alan Wang, PhD, Counsel, Goodwin & Procter LLP
Thomas Hou, Executive Director, Associate General Counsel, Iveric Bio

Sponsoring Committee:
Asian Affairs, Dih-Lin Wong, Chair

Co-Sponsoring Organizations:
Asia Practice Committee, Asian American Bar Association of New York
China Legal Education and Career Seminar Series

New York City Bar Association 42 West 44th Street New York, NY 10036

Please Sign In to Register